首页 | 本学科首页   官方微博 | 高级检索  
检索        

Orionin对急性肝衰竭小鼠的保护作用及其对肝组织细胞因子水平的影响*
引用本文:邓怡林,于合国,施敏,石翠翠,范建高,李光明.Orionin对急性肝衰竭小鼠的保护作用及其对肝组织细胞因子水平的影响*[J].实用肝脏病杂志,2017,20(3):294-297.
作者姓名:邓怡林  于合国  施敏  石翠翠  范建高  李光明
作者单位:200092 上海市 上海交通大学医学院附属新华医院消化内科(邓怡林,石翠翠,范建高,李光明); 同仁医院消化内科(施敏); 上海市计划生育科学研究所(于合国,刁华)
基金项目:*国家自然科学基金资助项目(编号:81400631/81570549)
摘    要:目的 探讨冬凌草甲素(Oridonin)对脂多糖/D-氨基半乳糖氨(LPS/D-Gal)联合诱导的急性肝衰竭(ALF)小鼠的保护作用及其对肝组织细胞因子水平的影响。方法 取150只小鼠,随机分成5组,每组 30 只。采用LPS/D-Gal腹腔注射建立小鼠ALF模型,设生理盐水对照组、Oridonin对照组、LPS/D-Gal诱导模型组和LPS/D-Gal处理及不同剂量Oridonin干预组。采用Real-time PCR法检测肝组织肿瘤坏死因子-α(TNF-α)、白细胞介素(IL)-1α、IL-1β和IL-6 mRNA水平。结果 模型组小鼠48 h存活率为0.0% (0/30),而两个Oridonin干预组小鼠48 h存活率分别提高至64.5% (19/30)和80.6% (24/30,P<0.01); 组织病理学检查显示模型组小鼠肝细胞呈大块或/和亚大块坏死,肝小叶结构消失,残存肝细胞肿胀、空泡变性,肝窦肿胀充血,炎细胞浸润。Oridonin干预组小鼠肝细胞坏死、空泡变性和炎细胞浸润等较模型组有明显的改善;模型组小鼠血清ALT和AST水平分别为(345.3 ± 54.1) U/L和(500.2±53.5) U/L,明显高于对照组的(42.3±0.6)U/L和(117.1±9.8)U/L,P<0.01],两个Oridonin干预组分别为 (303.9±39.5) U/L和(340.6±2.8) U/L及(130.2±38.3) U/L和 (209.8±36.2) U/L,P<0.05];模型组小鼠肝组织TNF-α、IL-1α、IL-1β和IL-6 mRNA水平显著高于正常对照组(P<0.01),而两个Oridonin干预组肝组织TNF-α、IL-1α、IL-1β和IL-6 mRNA水平显著低于模型组 (P<0.01)。结论 Oridonin对LPS/D-Gal诱导的ALF小鼠具有显著的保护作用,其作用机制可能与降低肝组织细胞因子水平有关。

关 键 词:急性肝衰竭  脂多糖  D-氨基半乳糖氨  冬凌草甲素  细胞因子  小鼠  
收稿时间:2016-10-14

Effect of oridonin on hepatic cytokine levels in mice with LPS/D-Gal-induced acute liver failure
Deng Yilin,Yu Heguo,Shi Min,et al..Effect of oridonin on hepatic cytokine levels in mice with LPS/D-Gal-induced acute liver failure[J].Journal of Clinical Hepatology,2017,20(3):294-297.
Authors:Deng Yilin  Yu Heguo  Shi Min  
Institution:Department of Gastroenterology,Xinhua Hospital Affiliated to Jiaotong University School of Medicine,Shanghai 200092,China
Abstract:Objective To investigate the effect of oridonin on hepatic cytokine levels in mice with polysaccharide(LPS)/ D-galactosamine(D-Gal)-induced acute liver failure. Methods 150 mice were randomly divided into five groups(30 in each group),e.g.,normal,oridonin control,model,oridonin-intervened,and oridonin-intervened for 12 days. ALF model was established in C57BL/6 mice by intraperitoneal injection of LPS/D-Gal. Results The 48 h lethality rate in LPS/D-Gal-induced group reached an extremely high level of 100%. However,the 48 h survival rates in two oridonin-intervened groups were 64.5% (19/30) and 80.6% (24/30,P<0.01);The damage in liver tissues was ameliorated in mice pretreated with oridonin as compared with that in the model group;Serum ALT and AST levels in model group were(345.3±54.1) U/L and(500.2±53.5) u/L,significantly higher than those in control group(42.3±0.6) U/L and(117.1±9.8) U/L,P<0.01] or in oridonin-treated group (303.9±39.5) U/L and (340.6±2.8) U/L or (130.2±38.3) U/L and (209.8±36.2) U/L,P<0.05];Administration of oridonin in mice with LPS/D-Gal-induced ALF significantly decreased mRNA levels of hepatic TNF-α,IL-1α, IL-1β and IL-6 compared with in model group(P<0.01). Conclusion Oridonin has a protective effect on mice with LPS/D-Gal-induced ALF,and the mechanism might be related to inhibition of hepatic cytokine activities.
Keywords:Acute liver failure  Lipopolysaccharide  D-galactosamine  Oridonin  Cytokines  Mice  
点击此处可从《实用肝脏病杂志》浏览原始摘要信息
点击此处可从《实用肝脏病杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号